Longitudinal analysis will be necessary to determine whether clonal expansion promoted by the acquisition of somatic EIF6 mutations delays or abrogates the emergence of hematological complications such as aplastic anemia, myelodysplastic syndrome (MDS), or acute myeloid leukemia (AML). The gene discussed is EIF6; the disease is idiopathic aplastic anemia.